13D Filing: Boyalife Investment Enters Into Agreement With Cesca Therapeutics Inc. (KOOL)

Page 3 of 67

Page 3 of 67 SEC Filing

CUSIP No. 157131103

(1)

NAME OF REPORTING PERSON:

Boyalife (Hong Kong) Ltd.

(2)

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) [X]

(b) [_]

(3)

SEC USE ONLY

 

(4)

 

SOURCE OF FUNDS

Cash Reserve (See Item 3)

(5)

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(D) OR 2(E)

[_]

(6)

CITIZENSHIP OR PLACE OF ORGANIZATION

China

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

(7)

SOLE VOTING POWER

58,823,529 (1)

(8)

SHARED VOTING POWER

0

(9)

SOLE DISPOSITIVE POWER

58,823,529 (1)

(10)

SHARED DISPOSITIVE POWER

0

(11)

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

58,823,529 (1)

(12)

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES

[_]

 

(13)

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

45.0%

 

(14)

 

TYPE OF REPORTING PERSON

CO

 

(1) Consists of 14,705,882 Shares and warrants to purchase 11,764,706
Shares acquired by Boyalife (Hong Kong) Ltd. pursuant to the transaction described below.

Explanatory Note

This Schedule 13D is being filed as a result
of a transaction with an initial closing occurring on February 13, 2016, and a subsequent closing occurring on February 16, 2016,
as further described herein.

3

Follow Thermogenesis Holdings Inc. (NASDAQ:THMO)

Page 3 of 67